Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease.
Boyer-Neumann
C
C
Dreyfus
M
M
Wolf
M
M
Veyradier
A
A
Meyer
D
D
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D002585:Cesarean Section; D004338:Drug Combinations; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D007518:Isoantibodies / Q000097:blood / Q000276:immunology*; D049590:Postpartum Period; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy* / Q000601:surgery; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000188:drug therapy*
D004338:Drug Combinations; D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII; D015942:Factor VIIa